Novel molecular imaging approach for subclinical detection of iritis and evaluation of therapeutic success. - Wikidata - wikimedia - TriplyDB

Novel molecular imaging approach for subclinical detection of iritis and evaluation of therapeutic success.

Novel molecular imaging approach for subclinical detection of iritis and evaluation of therapeutic success.

http://www.wikidata.org/entity/Q33617311

about

Molecular Imaging of Retinal Endothelial Injury in Diabetic Animals.Molecular imaging reveals elevated VEGFR-2 expression in retinal capillaries in diabetes: a novel biomarker for early diagnosis Noninvasive molecular imaging reveals role of PAF in leukocyte-endothelial interaction in LPS-induced ocular vascular injury VAP-1-mediated M2 macrophage infiltration underlies IL-1β- but not VEGF-A-induced lymph- and angiogenesis.Vascular adhesion protein 1 in the eye.Anti-inflammatory effects of cannabinoid CB(2) receptor activation in endotoxin-induced uveitis.A fast tumor-targeting near-infrared fluorescent probe based on bombesin analog for in vivo tumor imaging.Molecular Imaging of Subclinical Diabetic Retinopathy

P2860

Q33652612-CBCCCA84-2BC9-4049-8668-25BCA7C7EDCA Q34072640-BAA3D171-680D-4B51-A476-192D25903A1A Q34682448-822DF24E-87C0-4AFA-8FDC-949CA73F73B8 Q34805413-9DC8F421-62DB-440C-83B9-1B6883C90824 Q36942812-9F739A5F-AD6E-473F-ADD8-3F8859F32E7A Q37637761-E8ECD0AD-051C-494A-B9BC-1F2056BF635F Q39024393-1DA097D2-F4EA-4029-B0AB-78EB1082F32D Q42353374-71A0D318-C687-418E-96D0-00C37CABD4F4

P2860

Novel molecular imaging approach for subclinical detection of iritis and evaluation of therapeutic success.

http://www.wikidata.org/entity/Q33617311

description

2010 nî lūn-bûn

@nan

2010 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Novel molecular imaging approa ...... uation of therapeutic success.

@ast

Novel molecular imaging approa ...... uation of therapeutic success.

@en

type

label

Novel molecular imaging approa ...... uation of therapeutic success.

@ast

Novel molecular imaging approa ...... uation of therapeutic success.

@en

prefLabel

Novel molecular imaging approa ...... uation of therapeutic success.

@ast

Novel molecular imaging approa ...... uation of therapeutic success.

@en

P1433

Q33617311-A229C884-55A2-4F15-9814-FC91B36A1858

P1476

Q33617311-6848D639-865D-4C6D-AA38-106BAA66A1B5

P2093

Q33617311-0181E466-5668-40D3-88CD-CF2B264BC1D3

Q33617311-03EF208E-D7AA-4034-804F-D5B0D6C21D0B

Q33617311-0C6EC018-D010-46EC-A0C8-5B13CE41AF53

Q33617311-7992C9D0-EDA7-45B5-BA15-98C9A31F27CC

Q33617311-7F306556-FECE-4C7F-A819-45A484814F7B

Q33617311-D3CFA235-97B4-4C7B-9B98-9A1018690DA9

P2860

Q33617311-0B60B5C7-1FB1-48A6-98DB-C11A42219682

Q33617311-0D39A3E7-6B3F-4B6A-B031-5BEBB03CF620

Q33617311-135A7F8B-66CD-4805-AB0C-21D60C6CB543

Q33617311-1BC4944F-3468-496E-B055-FF5D544D5D01

Q33617311-36B6F018-D058-4E1D-B9B0-C1924F557FC7

Q33617311-669C62A6-1BCC-4799-85B8-A150CEE20E51

Q33617311-6D4ED66E-F3D9-4B01-BEEC-E4B918A49507

Q33617311-6E09E19F-DE28-4012-9EDB-6FB74413ABE2

Q33617311-839C7218-34B7-49EB-9070-F12177385519

Q33617311-986731EC-921B-454A-8485-5D47CC10A2F7

P304

Q33617311-A33B637D-623C-47D7-933D-2323F8F57014

P31

Q33617311-270A93BC-E09B-4B23-924B-037DD0713C0F

P356

Q33617311-AF7CAB9A-1E0F-444C-B276-29CF73B48443

P407

Q33617311-2687CBA2-8763-44E1-9830-BB0C79289FFB

P433

Q33617311-2239A79D-3EEF-46B4-BDF3-461BE72D6A40

P478

Q33617311-16808FBB-50E9-4AF0-A080-7C95FF7D2E59

P50

Q33617311-61347240-AB56-4E41-B63E-FFF5E79C13C1

P577

Q33617311-00C6CA90-0D60-4114-9FAC-BBC03468C98D

P5875

Q33617311-A7C82045-D29C-49CB-90EB-DB3C312CDB14

P698

Q33617311-176B7416-6F24-4B3F-83E5-19F4741D1CED

P932

Q33617311-F1FD1F36-23D9-4972-88E7-A00ECAB4CA0D

P356

AJPATH.2010.100007

P1433

The American Journal of Pathology

P1476

Novel molecular imaging approa ...... luation of therapeutic success

@en

P2093

Alexander Schering

http://www.w3.org/2001/XMLSchema#string

Dawei Sun

http://www.w3.org/2001/XMLSchema#string

Fang Xie

http://www.w3.org/2001/XMLSchema#string

Ping Liu

http://www.w3.org/2001/XMLSchema#string

Shintaro Nakao

http://www.w3.org/2001/XMLSchema#string

Souska Zandi

http://www.w3.org/2001/XMLSchema#string

P2860

Relevance of L-selectin shedding for leukocyte rolling in vivo.

L-selectin shedding regulates leukocyte recruitment.

Leukocyte rolling in vivo is mediated by P-selectin glycoprotein ligand-1.

Leukocyte trafficking in experimental autoimmune uveitis in vivo.

In vivo imaging of endothelial injury in choriocapillaris during endotoxin-induced uveitis.

Superior sensitivity of novel molecular imaging probe: simultaneously targeting two types of endothelial injury markers.

Endotoxin-induced uveitis in rats as a model for human disease.

Immune mechanisms in uveitis. What can be learned from in vivo imaging?

P-selectin glycoprotein ligand 1 is a ligand for L-selectin on neutrophils, monocytes, and CD34+ hematopoietic progenitor cells

A mechanism for the antiinflammatory effects of corticosteroids: the glucocorticoid receptor regulates leukocyte adhesion to endothelial cells and expression of endothelial-leukocyte adhesion molecule 1 and intercellular adhesion molecule 1

P304

39-48

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2353/AJPATH.2010.100007

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

177

http://www.w3.org/2001/XMLSchema#string

P50

Ali Hafezi-Moghadam

P577

2010-06-25T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

44802974

http://www.w3.org/2001/XMLSchema#string

P698

20581051

http://www.w3.org/2001/XMLSchema#string

P932

2893649

http://www.w3.org/2001/XMLSchema#string